Zobrazeno 1 - 2
of 2
pro vyhledávání: '"D. M. W. W. te Loo"'
Autor:
Rob Pieters, Marc Bierings, Wim J. E. Tissing, Ron A. A. Mathôt, C. van den Bos, G. J. L. Kaspers, F.P.J.M. de Haas, Christian M. Zwaan, D. M. W. W. te Loo, M. van Westreenen, I. M. van der Sluis, Sebastiaan D. T. Sassen
Publikováno v:
Clinical Infectious Diseases, 71(8), E281-E288. Oxford University Press
Clinical infectious diseases, 71(8), e281-e288. Oxford University Press
Sassen, S D T, Mathôt, R A A, Pieters, R, De Haas, V, Kaspers, G J L, Van Den Bos, C, Tissing, W J E, Te Loo, D M W W, Bierings, M B, Van Westreenen, M, Van Der Sluis, I M & Zwaan, C M 2020, ' Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients ', Clinical Infectious Diseases, vol. 71, no. 8, pp. E281-E288 . https://doi.org/10.1093/cid/ciz1163
Clinical Infectious Diseases, 71(8), E281-E288
Clinical infectious diseases, 71(8), e281-e288. Oxford University Press
Sassen, S D T, Mathôt, R A A, Pieters, R, De Haas, V, Kaspers, G J L, Van Den Bos, C, Tissing, W J E, Te Loo, D M W W, Bierings, M B, Van Westreenen, M, Van Der Sluis, I M & Zwaan, C M 2020, ' Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients ', Clinical Infectious Diseases, vol. 71, no. 8, pp. E281-E288 . https://doi.org/10.1093/cid/ciz1163
Clinical Infectious Diseases, 71(8), E281-E288
Background Ciprofloxacin is used as antimicrobial prophylaxis in pediatric acute lymphoblastic leukemia (ALL) to decrease infections with gram-negative bacteria. However, there are no clear guidelines concerning prophylactic dose. Aims To determine t
Autor:
Sebastiaan Sassen, R. A. A. Mathôt, Rob Pieters, V. de Haas, G. J .L. Kaspers, C. van den Bos, Wim J. E. Tissing, D. M. W. W. te Loo, M. B. Bierings, I. M. van der Sluis, C. Michel Zwaan
Publikováno v:
SSRN Electronic Journal.